` ACB (Aurora Cannabis Inc) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

ACB
vs
S&P TSX Composite Index (Canada)

Over the past 12 months, ACB has underperformed S&P TSX Composite Index (Canada), delivering a return of -26% compared to the S&P TSX Composite Index (Canada)'s 16% growth.

Stocks Performance
ACB vs S&P TSX Composite Index (Canada)

Loading
ACB
S&P TSX Composite Index (Canada)
Add Stock

Performance Gap
ACB vs S&P TSX Composite Index (Canada)

Loading
ACB
S&P TSX Composite Index (Canada)
Difference

Performance By Year
ACB vs S&P TSX Composite Index (Canada)

Loading
ACB
S&P TSX Composite Index (Canada)
Add Stock

Competitors Performance
Aurora Cannabis Inc vs Peers

S&P TSX Composite Index (Canada)
ACB
LLY
JNJ
NOVO B
ROG
Add Stock

Aurora Cannabis Inc
Glance View

Market Cap
392.9m CAD
Industry
Pharmaceuticals

Aurora Cannabis, Inc. engages in the production, distribution and sale of cannabis products. The firm's principal business lines are focused on the production, distribution and sale of cannabis and cannabis related products in Canada and internationally. The firm's portfolio of brands includes Aurora, Aurora Drift, San Rafael '71, Daily Special, MedReleaf, CanniMed, Whistler, Reliva and KG7 CBD. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia; and Odense, Denmark. The firm is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets. The company produces approximately 150,000 kilograms (kg) of cannabis biomass annually. Its subsidiaries include 1769474 Alberta Ltd., 2105657 Alberta Inc., Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, and Reliva, LLC, among others.

ACB Intrinsic Value
11.82 CAD
Undervaluation 39%
Intrinsic Value
Price
Back to Top